Oxidative and malondialdehyde modification of low-density lipoprotein: A comparative study of binding and degradation by macrophages and endothelial cells

British Journal of Biomedical Science

Volumn 55, Issue 3, 1998, Pages 192-198

  Zhou, Mei ^a   Chen, Yuan ^a   Liu, Shangxi ^a   Ding, Zhenhua ^a   Pang, Zhanjun ^a   Wan, Jennifer ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Binding, competitive; Lipoproteins, LDL; Macrophages; Malondialdelhyde modification; Oxidative modification; Receptors, LDL

Indexed keywords

CELL RECEPTOR; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN MODIFICATION; VASCULAR ENDOTHELIUM;

ANIMALS; CELL CULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES, PERITONEAL; MALONDIALDEHYDE; MICE; OXIDATION-REDUCTION;

ANIMALIA;

EID: 0031756156     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Steinberg D, Parthasarathy S, Carew TE et al. Modification of low density lipoprotein that increases its atherogenicity. N Engl J Med 1989; 320:915-24.
2. Steinbrecher UP, Zhang H, Loughced M. Role of oxidatively modified LDL in atherosclerosis. Free Radic Dial Med 1990; 9:155-68.
3. Steinberg D, Witztum JL. Lipoprotein and atherogenesis. J Am Med Assoc 1990; 264:3047-52.
4. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88:1785-92.
5. Parthasarathy S, Steinberg D, Witztum JL. The role of oxidized low density lipoprotein in the pathogenesis of atherosclerosis. Annu Rev Med 1992; 43:219-25.
6. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-8.
7. Fowler S, Shio H, Haley WJ. Characterization of lipid loaded aortic cells from cholesterol-fed rabbits. IV Investigation of macrophage-like properties of aortic cell population. Lab Invest 1979; 4:372-8.
8. Schaffner T, Taylor K, Bartucci E. Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. Am J Pathol 1980; 100:57-80.
9. Gerrity RG. The role of the monocyte in atherogenesis. I Transition of blood-borne monocytes into foam cells in fatty lesion. Am J Pathol 1981; 103:181-90.
10. Heinecke JW. Free radical modification of low density lipoprotein: Mechanism and biological consequences. Free Radic Biol Med 1987; 3:65-73.
11. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylatcd low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979; 76:333-7.
12. Fogelman AM, Schecter IS, Seager J et al. Malondialdehyde alteration of low density lipoprotein leads to cholesterol ester accumulation in human monocyte macrophage. Proc Natl Acad Sci USA 1980; 77:2214-18.
13. Rosenfeld ME, Palinki W, Yla-Herttuala S et al. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Atherosclerosis 1990; 10:336-49.
14. Haberland ME, Fong D, Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanab Heritable Hyperlipidaemic Rabbits. Science 1988; 241:215-18.
15. Arai H, Kita T, Yokode M et al. Multiple receptors for modified low density lipoprotein in mouse peritoneal macrophage: Different uptake mechanisms for acctylated and oxidized low density lipoproteins. Biochem Biophys Res Commun 1989; 159: 1375-82.
16. Kume N, Arai H, Kawa: C et al. Receptors for modified low-density lipoprotein on human endothelial cell: different recognition for acetylated low density lipoprotein and oxidized low density lipoprotein. Biochim Biophys Acta 1991; 1091:63-7.
17. Shang Xi L, Mei Z, Yuan C et al. Upoperoxidative injury to macrophages by oxidatively modified low density lipoprotein may play an important role in foam cell formation. Atherosclerosis 1996; 121:55-61.
18. Redgrave TG, Robeens DCK, West CE. Separation of plasma lipoprotein by density gradient ultracentrifugation. Anal Biochem 1975; 65:42-9.
19. Cheng P, Zhou M, Yang SL. Effects of oxidatively modified low density lipoprotein on cultured human umbilical cord vein endothelial cells. Acad J First A Med Coll PLA 1991; 11:296-300.
20. Ding ZH, Zhou M, Chen Y, Fang YZ. Inhibitory effect of china green tea polyphenol on the oxidative modification of low density protein by macrophages. Med Sci Res 1991; 19:767-8.
21. Lowry OH, Rosebrough NT, Farr AL, Rondoll RD. Protein measurement with folin phenol reagent. J Biol Chem 1951; 193: 265-75.
22. Estervauer H, Dieber-Rotheneder M, Waeg G et al. Biochemical structural and functional properties of oxidized low density lipoprotein. Chem Res Toxicol 1990; 3(2):77-92.
23. Hoff HF, Whilaker TE, O'N'eil J. Oxidation of low density lipoprotein leads to particle aggregation and altered macrophage recognition. J Biol Chem 1992; 267:602-9.
24. Yuan Chen, Mei Zhou, Shangxi Liu et al. Oxidative and malondialdehyde modification of low-density lipoproteins: a comparative study. Br J Biomed Sci 1997; 54:159-65.
25. Ikuo I, Toshimori I, Kazuo M et al. Macrophage colony stimulating factor prevents the progression of atherosclerosis in Watanabe heritable hyperlipidaemic rabbits. Atherosclerosis 1992; 93:245-54.